Cap Apremate Kit
Aprepitant Capsules IP 125 mg / 80 mg. Specifically designed for the effective management and prevention of chemotherapy-induced nausea and vomiting (CINV).
Clinical Indication:
- High-quality Aprepitant formulation
- Optimized dosage (125mg & 80mg)
- Trusted supportive care in Rheumatology